Pure Global AI
NCT06358547Not yet recruiting

Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Women Aged 37-41 Years

Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Women Aged 37-41 Years - a Randomized Controlled Multicenter Trial
Rigshospitalet, DenmarkClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Infertility
Drug/Device/Intervention
PGT-A
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Rigshospitalet, Denmark
Location
København Ø, Denmark
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Apr 01, 2029
Enrollment
590 participants
Primary outcome

Live birth rate per first embryo transfer,Cumulative live birth rate after one complete ART treatment

Summary

A multinational multi-centre, randomized, controlled non-blinded trial with participation of
 three fertility clinics in Denmark and one in Spain to assess the efficacy and safety of
 preimplantation genetic testing for aneuploidy (PGT-A) in 37-41-year-old women.

ICD-10 classifications
Female infertilityMale infertilityFemale infertility, unspecifiedFemale infertility of other originFemale infertility of uterine origin
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06358547
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06358547 through Pure Global AI's free database. This phase not specified trial is sponsored by Rigshospitalet, Denmark and is currently Not yet recruiting. The study focuses on Infertility. Target enrollment is 590 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.